Thyme Care, which focuses on filling cancer treatment gaps via a virtual navigation platform, raised a $125M Series E at a $2B+ valuation, up from $1B+ in 2025
CNBC Ian Thomas
Related Coverage
- Thyme Care Closes $125+ Million Series E, Establishes Thyme Companies to Broaden Its Impact Across the Oncology Ecosystem Thyme Care
- Thyme Care raises $125M+ as Robin Shah builds an oncology parent company RuntimeWire
- Thyme Care announces $125 million raise, launches new parent company Nashville Business Journal · Nikki Ross
- Thyme Care Closes Over $125M Series E Funding FinSMEs
- Thyme Care Raises $125M, Launches New Oncology Parent Entity MedCity News · Marissa Plescia
- Thyme Care Raises Over $125 Million Series E At More Than $2 Billion Valuation And Launches Thyme Companies Pulse 2.0 · Amit Chowdhry
- Thyme Care doubles valuation to $2B+ with $125M raise to tackle gaps in cancer care Tech Funding News · Abhinaya Prabhu
- Thyme Care Secures Over $125M, Launches Thyme Companies to Scale Oncology Innovation HIT Consultant · Fred Pennic
Discussion
-
Jessa Kelley
Jessa Kelley
on linkedin
For those who know me well, you've probably heard me reflect on how meaningful my time at Thyme Care has been. …
-
Etan Raskas
Etan Raskas
on linkedin
I joined Thyme Care because I was deeply inspired by the mission-driven team Robin Shah Bobby Green, M.D. and Brad Diephuis had built. …
-
Robin Shah
Robin Shah
on linkedin
Six years ago, Bobby Green, M.D. and I started Thyme Care with a belief that the experience of navigating cancer could and should be better. …
-
Dan Mendelson
Dan Mendelson
on linkedin
Great progress with our portfolio company Thyme Care, now Thyme Companies. — Morgan Health just led a $125M Series E round alongside CVS Health, Humana, Frist Cressey Ventures, a16z Bio + Health …